Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Common Equity (2020 - 2025)

Historic Common Equity for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to -$20.1 million.

  • Celularity's Common Equity fell 21628.47% to -$20.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.1 million, marking a year-over-year decrease of 21628.47%. This contributed to the annual value of $8.8 million for FY2024, which is 7842.53% down from last year.
  • As of Q3 2025, Celularity's Common Equity stood at -$20.1 million, which was down 21628.47% from -$25.5 million recorded in Q2 2025.
  • In the past 5 years, Celularity's Common Equity ranged from a high of $198.9 million in Q4 2022 and a low of -$47.4 million during Q2 2021
  • Its 5-year average for Common Equity is $57.4 million, with a median of $31.2 million in 2024.
  • Data for Celularity's Common Equity shows a peak YoY increase of 182431.85% (in 2021) and a maximum YoY decrease of 104809.08% (in 2021) over the last 5 years.
  • Over the past 5 years, Celularity's Common Equity (Quarter) stood at $99.4 million in 2021, then surged by 100.07% to $198.9 million in 2022, then tumbled by 79.41% to $41.0 million in 2023, then tumbled by 78.43% to $8.8 million in 2024, then tumbled by 327.38% to -$20.1 million in 2025.
  • Its last three reported values are -$20.1 million in Q3 2025, -$25.5 million for Q2 2025, and -$5.5 million during Q1 2025.